Interestingly, within the driver genes context, hematological cancers (i.e., non-Hodgkin’s lymphoma (Lymph-BNHL), DLBCL) and MB had the highest signature contribution of AID provoked mutations. The gene discussed is AICDA; the disease is non-Hodgkin lymphoma.